Navigation Links
Comparative Effectiveness Research Study in Mayo Clinic Proceedings Demonstrated Asthma Patients Had Better Overall Results with Oral Controllers than Inhaled Products
Date:8/26/2009

Patients who had medication in their possession for 80 percent of the year or longer were considered to be adherent to therapy.

About HealthCore

HealthCore, based in Wilmington, Del., is the clinical outcomes research subsidiary of WellPoint. HealthCore has a team of highly experienced researchers including physicians, biostatisticians, pharmacists, epidemiologists, health economists and other scientists who study the "real world" safety and effectiveness of drugs, medical devices and care management interventions. HealthCore offers insight on how to best use this data and communicates these findings to health care decision-makers to support evidence-based medicine, product development decisions, safety monitoring, coverage decisions, process improvement and overall cost-effective health care. For more information, go to www.healthcore.com.


'/>"/>
SOURCE HealthCore and WellPoint, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Charlotte Attorney Calls on North Carolina Senate to Pass "Comparative Negligence" Bill in Order to Better Protect Injury Victims in State
2. NCCN Will Convene National Policy Summit on Comparative Effectiveness in Cancer Care
3. Physician groups support comparative effectiveness provisions in proposed legislation
4. 'Comparative Effectiveness' Research Addresses Options for Treating Prostate Cancer
5. Psoriasis Cure Now Welcomes Institute of Medicine Report Urging Comparative Effectiveness Research on Psoriasis, But Worries About Risk of Rationing
6. AMP urges inclusion of molecular diagnostic tests in comparative effectiveness research
7. National Hispanic Medical Association to Focus Health Reform on Health Disparities and Comparative Effectiveness Research
8. Health Plans Prepare for Health Care Reform: Comparative Effectiveness, Consumerism Drive Future Changes, According to Deloitte Study
9. PIPC Supports New Comparative Effectiveness Research (CER) Bill
10. BioHorizons Reports on Comparative 3-Year Dental Implant Study Showing Significant Crestal Bone and Soft Tissue Retention Using Laser-Lok(R) Microchannels
11. Deloitte Comparative Effectiveness Study Evaluates Potential Savings Opportunities for U.S. Health Care System

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)..., WASHINGTON,Nov.23/PRNewswire/--TheLupusFoundatio...rate35yearsofsuccessprovidingfreeday-to-dayeducati...ndtheirfamiliesinthegreaterD.C.area.LFAGW,s35thAnn...0p.m.-2:30p.m.atB.Smith,s,50MassachusettsAve.,N.E....ketsareavailableat$100each.Tablesponsoropportuniti...
(Date:11/23/2009)... After suffering from women,s h...air is growing back and she,s sharing her progress...of other women through the release of her video di...r before and during her treatment. , ...ime hair loss sufferer Zsanett Siklosi has relea...
(Date:11/23/2009)..., ActingSecretaryEncouragesUseofPAPreferredProduct...wire-USNewswire/--ToensurethatyourfamilyhasasafeTh...ussellReddingisurgingresidentstofollowafewbasicfoo...s. ,, "Followingandunderstandingproperfoodhandl...sureyourThanksgivingdinnerissafetoeat,"saidRedding...
(Date:11/23/2009)..., WASHINGTON,Nov.23/PRNewswire-USNewswire/--TheAme...alchildren,spublishing,education,andmediacompany,a...ncecurriculumdesignedtosparkinterestinthefieldsofs...citingcareeropportunitiesinhematology. ,, "Many...oolaboutHemotheMagnificent,whichmadelearningaboutb...
(Date:11/23/2009)...LAND, Ore. Low-income children who don,t access h...e long term are significantly more likely to have ...cording to a new study published in the journal P...informing the financing and delivery of quality he..., "In the current policy debates about health ins...
Breaking Medicine News(10 mins):Health News:Washington Lupus Chapter Celebrates 35th Anniversary on December 5 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 3Health News:Pennsylvania Agriculture Department Encourages Proper Food Handling, Offers Safety Tips for Thanksgiving 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 3Health News:Children who lack continuity with a regular health care provider miss needed services 2Health News:Children who lack continuity with a regular health care provider miss needed services 3
...uda, Dec. 8 Warner Chilcott Limited (Nasdaq: WC...sidiaries and Hospira, Inc. ("Hospira") have recei... Pharmaceutical Company, Inc. ("Mutual") and Mylan... and 75 mg delayed-release tablets. , , DORY...
...lic abnormalities better regulated when following ...y News) -- In older adults at risk for heart disea...xed nuts may help manage metabolic syndrome, accor...sure and high glucose levels -- all of which are r...
... toward lower-cost drugs, study finds , , ...rescribing system that tells doctors which drugs a... new study finds. , "One of the challenges physici...rd Medical School and lead author of a report in t...
... The use of "brain enhancing" d...ior, simpler, natural solution exists: a treadmill... 8, 2008 -- Purported "brain enhancement"...stitute of Mental Health. This dramatic rise in us...
... DATATRAK International, Inc.,(Nasdaq: DATA ), ...l eClinical,solutions for the clinical trials indu...om the Listing Qualifications Staff (the "Staff") ...on stockholders, equity,requirement for continued ...
...eplacement for Dummies is an authoritative guide e...ays to treat it. , , NEW YORK, Dec. 8 Renown...M.D., F.A.A.D., and Dr. William Rassman, have co-a...transplant options. The book, published by John W...
Other Medicine News:Health News:Warner Chilcott Announces Receipt of Paragraph IV Certification Notices 2Health News:Warner Chilcott Announces Receipt of Paragraph IV Certification Notices 3Health News:Mediterranean Diet Enriched With Nuts Cuts Heart Risks 2Health News:Electronic Prescribing Saves Patients Money 2Health News:Electronic Prescribing Saves Patients Money 3Health News:Brain Boosting Drugs vs. Walking: Treadmill Desk Manufacturer Promotes Common Sense 2Health News:Brain Boosting Drugs vs. Walking: Treadmill Desk Manufacturer Promotes Common Sense 3Health News:DATATRAK International, Inc. Receives Notice from NASDAQ 2Health News:DATATRAK International, Inc. Receives Notice from NASDAQ 3Health News:Hair Transplant Surgeons Author Hair Loss for Dummies Book 2Health News:Hair Transplant Surgeons Author Hair Loss for Dummies Book 3
(Date:11/23/2009)...swire/--BioTrendsResearchGroup,Inc.releasedWave2of...ndinamulti-phasesyndicatedmarketresearchprojecttra...roughthefirstsixmonthsofproductavailability.Eachwa...uniqueNephrologistsandqualitativeinformationfromas...staclestouse,reasonstouse,typicalpatienttypes,prod...
(Date:11/23/2009)...Newswire/--AMDLASERSannouncedthisweekthatitcontinu...ringwithprestigiousindustry-leaderDr.LarryRosentha...heexclusivesofttissuediodelaserusedduringallintern...top2%ofdentists. ,, (Photo: http://www.newscom....hgreatpleasurethatIproudlyannounceourpartnership.S...
(Date:11/23/2009)...RNewswire-FirstCall/--RaptorPharmaceuticalCorp.("R...thepresentationofclinicaltrialdataonNGX426,theComp...eptorantagonist,atthe12thInternationalConferenceon...ovember20-21inSanFrancisco.Theresultsofthestudyled...gyattheCenterforPainMedicineoftheUniversityofCalif...
Breaking Medicine Technology:Reported Use of AMAG's Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are 'On the Verge' of Use 2AMD LASERS Announces New Partnership with Dr. Larry Rosenthal and Aesthetic Advantage 2Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 2Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 3Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 4Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 5Shifting baselines confound river restoration 9746 1Shifting baselines confound river restoration 9746 2DaVita CEO Kent Thiry Honored as One of Modern Healthcares 100 Most Powerful People in Healthcare 55783 1DaVita CEO Kent Thiry Honored as One of Modern Healthcares 100 Most Powerful People in Healthcare 55783 2Cumberland Pharmaceuticals to Present at UBS Global Life Sciences Conference in New York on September 21 2009 55779 1Cumberland Pharmaceuticals to Present at UBS Global Life Sciences Conference in New York on September 21 2009 55779 2
...--Jun 11, 2007 - Neurogen,Corporation (Nasdaq: NRG... clinical studies for NG2-73, the Company,s lead c...ted today at the SLEEP,2007 Annual Meeting of the ...Minneapolis, Minnesota. Two Phase 2b clinical stud...urrently being,conducted by the Company. Data pres...
...EGEVILLE, Pa.--(BUSINESS WIRE)--Jun,13, 2007 - Amg...sion of Wyeth (NYSE:WYE), today announced the pres...afety profile of Enbrel(R),(etanercept) was mainta...to-severe juvenile rheumatoid arthritis (JRA) who,...hronic autoimmune,disease of childhood that is som...
Other Medicine Technology:Neurogen Proprietary Insomnia Compound Data Presented at Associated,Professional Sleep Societies Annual Meeting 2Neurogen Proprietary Insomnia Compound Data Presented at Associated,Professional Sleep Societies Annual Meeting 3Neurogen Proprietary Insomnia Compound Data Presented at Associated,Professional Sleep Societies Annual Meeting 4Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 2Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 3Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 4Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 5Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 6Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 7Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 8
Sugita Aneurysm Clip J-Shaped (M)
Sugita Aneurysm Clip 1/4 Cvd. (L)
Sugita Aneurysm Clip 45 Angled (L)
Sugita Aneurysm Clip L-Shaped (S)
Medicine Products: